nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Discrete Choice Experiment to Elicit General Population Preferences Around the Factors Influencing the Choice to Make Clinical Negligence Claims
|
Rowen, Donna |
|
|
25 |
8 |
p. 1404-1415 |
artikel |
2 |
Americans’ Health Priorities During the COVID-19 Pandemic
|
Cook, Joseph |
|
|
25 |
8 |
p. 1281-1289 |
artikel |
3 |
A National Catalog of Mapped Short-Form Six-Dimension Utility Scores for Chronic Conditions in the United States From 2010 to 2015
|
Song, Hyun Jin |
|
|
25 |
8 |
p. 1328-1335 |
artikel |
4 |
A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues
|
Podolsky, Meghan I. |
|
|
25 |
8 |
p. 1298-1306 |
artikel |
5 |
Author Reply
|
Fanning, Laura |
|
|
25 |
8 |
p. 1460-1462 |
artikel |
6 |
Brief Cost Analysis of Surgical Personal Protective Equipment During the COVID-19 Pandemic
|
Kapinos, Kandice A. |
|
|
25 |
8 |
p. 1317-1320 |
artikel |
7 |
“Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs
|
Cheung, Douglas C. |
|
|
25 |
8 |
p. 1307-1316 |
artikel |
8 |
Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report
|
Drummond, Michael F. |
|
|
25 |
8 |
p. 1257-1267 |
artikel |
9 |
Common Sense in Dollars and Cents: Context Matters in Cost-Effectiveness Checklist Evaluations
|
Shaker, Marcus |
|
|
25 |
8 |
p. 1459-1460 |
artikel |
10 |
Considering Severity in Health Technology Assessment: Can We Do Better?
|
Skedgel, Chris |
|
|
25 |
8 |
p. 1399-1403 |
artikel |
11 |
Copyright/Subscription
|
|
|
|
25 |
8 |
p. vi |
artikel |
12 |
Defining a Core Data Set for the Economic Evaluation of Precision Oncology
|
Pollard, Samantha |
|
|
25 |
8 |
p. 1371-1380 |
artikel |
13 |
Development and Pilot Test of the Registry Evaluation and Quality Standards Tool: An Information Technology–Based Tool to Support and Review Registries
|
Allen, Alexander |
|
|
25 |
8 |
p. 1390-1398 |
artikel |
14 |
Editorial Board
|
|
|
|
25 |
8 |
p. vii |
artikel |
15 |
Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials
|
Dijk, Stijntje W. |
|
|
25 |
8 |
p. 1268-1280 |
artikel |
16 |
Preexisting Condition Protections Under the Affordable Care Act: Changes in Insurance Coverage, Premium Contributions, and Out-of-Pocket Spending
|
Zhao, Jingxuan |
|
|
25 |
8 |
p. 1360-1370 |
artikel |
17 |
Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands
|
Mouter, Niek |
|
|
25 |
8 |
p. 1290-1297 |
artikel |
18 |
Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic
|
Murteira, Rodrigo |
|
|
25 |
8 |
p. 1321-1327 |
artikel |
19 |
Systematic Review on the Cost-Effectiveness of Seasonal Influenza Vaccines in Older Adults
|
Loong, Desmond |
|
|
25 |
8 |
p. 1439-1458 |
artikel |
20 |
Table of Contents
|
|
|
|
25 |
8 |
p. i-v |
artikel |
21 |
The Impact of Banning Electronic Nicotine Delivery Systems on Combustible Cigarette Sales: Evidence From US State-Level Policies
|
Xu, Yingying |
|
|
25 |
8 |
p. 1352-1359 |
artikel |
22 |
The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies
|
Ma, Siyu |
|
|
25 |
8 |
p. 1336-1343 |
artikel |
23 |
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis
|
Vellekoop, Heleen |
|
|
25 |
8 |
p. 1428-1438 |
artikel |
24 |
The Role of Attribute Screening and Choice Set Formation in Health Discrete Choice Experiments: Modeling the Impact of Benefit and Risk Attributes
|
Veldwijk, Jorien |
|
|
25 |
8 |
p. 1416-1427 |
artikel |
25 |
The Sensitivity and Specificity of Repeated and Dominant Choice Tasks in Discrete Choice Experiments
|
Jonker, Marcel F. |
|
|
25 |
8 |
p. 1381-1389 |
artikel |
26 |
Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma
|
Chen, Alice J. |
|
|
25 |
8 |
p. 1344-1351 |
artikel |